Mvasi® (bevacizumab-awwb)
for Renal Cell Carcinoma

Mvasi (bevacizumab-awwb) is a biosimilar to Avastin used alone or with other treatments for certain brain tumors and cancers of the kidney, liver, lung, colon, rectum, cervix, ovary, fallopian tube, and abdominal lining. It works by blocking VEGF, a protein that promotes blood vessel growth, thereby reducing the tumor's blood supply and slowing cancer progression.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Renal Cell Carcinoma - RCC